Centene CORP 8-K filings

Centene Corporation reaffirms its full-year 2024 adjusted diluted EPS guidance despite higher than expected Medicaid claims, while also noting strong Marketplace performance and a projected premium deficiency reserve.

Centene Corporation held its annual meeting on May 14, 2024, where shareholders elected ten directors, approved executive compensation in a non-binding vote, ratified the appointment of KPMG as auditor, and rejected a shareholder proposal on climate risk.

Centene Corporation reported strong first-quarter 2024 results, exceeding expectations and leading to an increase in the company's full-year guidance.

James E. Murray has retired from Centene Corporation, effective March 29, 2024, as previously announced.

Centene Corporation expects to reaffirm its 2024 adjusted diluted earnings per share guidance of greater than $6.70 during a presentation at the Barclays 26th Annual Global Healthcare Conference.

Centene Corporation announced its 2023 financial results, exceeding adjusted EPS guidance and increasing its 2024 premium and service revenue guidance by $2.5 billion.